Lycopene and risk of prostate cancer

Medicine (United States)

Volumn 94, Issue 33, 2015, Pages e1260-

  Chen, Ping ^a   Zhang, Wenhao ^a   Wang, Xiao ^a   Zhao, Keke ^a   Negi, Devendra Singh ^a   Zhuo, Li ^a   Qi, Mao ^a   Wang, Xinghuan ^a   Zhang, Xinhua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYCOPENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAROTENOID;

BODY MASS; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; DOSE RESPONSE; FOLLOW UP; HUMAN; MALE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR; SCIENCEDIRECT; SYSTEMATIC REVIEW; CHEMISTRY; OUTCOME ASSESSMENT; PHYTOTHERAPY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TOMATO;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; FOLLOW-UP STUDIES; HUMANS; LYCOPERSICON ESCULENTUM; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHYTOTHERAPY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84943149839     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001260     Document Type: Review

References (65)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-E386
2. Ambrosini GL, Fritschi L, De Klerk NH, et al. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia. Ann Epidemiol. 2008; 18: 364-370
3. Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015; 27: 2-12
4. Han S, Zhang S, Chen W, et al. Analysis of the status and trends of prostate cancer incidence in China. Chin Clin Oncol. 2013; 18: 330-334
5. Kavanaugh CJ, Trumbo PR, Ellwood KC, et al. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 2007; 99: 1074-1085
6. Rackley JD, Clark PE, Hall MC. Complementary and alternative medicine for advanced prostate cancer. Urol Clin North Am. 2006; 33: 237-246
7. Norrish AE, Jackson RT, Sharpe SJ, et al. Prostate cancer and dietary carotenoids. Am J Epidemiol. 2000; 151: 119-123
8. Deneo-Pellegrini H, De Stefani E, Ronco A, et al. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer. 1999; 80: 591-597
9. Jain MG, Hislop GT, Howe GR, et al. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancer. 1999; 34: 173-184
10. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000; 92: 61-68
11. Jian L, Du CJ, Lee AH, et al. Do dietary lycopene and other carotenoids protect against prostate cancer?. Int J Cancer. 2005; 113: 1010-1014
12. Lu QY, Hung JC, Heber D, et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2001; 10: 749-756
13. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer. 1997; 76: 678-687
14. Hodge AM, English DR, McCredie MR, et al. Foods, nutrients and prostate cancer. Cancer Causes Control. 2004; 15: 11-20
15. Vogt TM, Mayne ST, Graubard BI, et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol. 2002; 155: 1023-1032
16. Kirsh VA, Mayne ST, Peters U, et al. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 92-98
17. Agalliu I, Kirsh VA, Kreiger N, et al. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiol. 2011; 35: 353-361
18. Kristal AR, Arnold KB, Neuhouser ML, et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol. 2010; 172: 566-577
19. Schuurman AG, Goldbohm RA, Brants HA, et al. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control. 2002; 13: 573-582
20. Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014; 106: djt430
21. Kristal AR, Till C, Platz EA, et al. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2011; 20: 638-646
22. Key TJ, Appleby PN, Allen NE, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007; 86: 672-681
23. Nomura AM, Stemmermann GN, Lee J, et al. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev. 1997; 6: 487-491
24. Peters U, Leitzmann MF, Chatterjee N, et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007; 16: 962-9 68
25. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999; 59: 1225-1230
26. Huang HY, Alberg AJ, Norkus EP, et al. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003; 157: 335-344
27. Hsing AW, Comstock GW, Abbey H, et al. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst. 1990; 82: 941-946
28. Wu K, Erdman JW Jr, Schwartz SJ, et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2004; 13: 260-269
29. Beilby J, Ambrosini GL, Rossi E, et al. Serum levels of folate, lycopene, beta-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr. 2010; 64: 1235-1238
30. Karppi J, Kurl S, Nurmi T, et al. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol. 2009; 19: 512-518
31. Goodman GE, Schaffer S, Omenn GS, et al. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev. 2003; 12: 518-526
32. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a metaanalysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004; 13: 340-345
33. Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-Analysis of prospective studies. J Nutr Sci Vitaminol (Tokyo). 2013; 59: 213-223
34. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012
35. Orsini N, Li R, Wolk A, et al. Meta-Analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012; 175: 66-73
36. Yoshimura I. The effect of measurement error on the dose-response curve. Environ Health Persp. 1990; 87: 173-178
37. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. 2011. www.ohri.ca/programs/clinical-epidemiology/oxford. asp. Accessed December 2014
38. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-Analysis. Am J Epidemiol. 1992; 135: 1301-1309
39. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects metaanalyses. Stat Med. 2010; 29: 1282-1297
40. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988; 80: 1198-1202
41. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006; 6: 40-57
42. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002; 21: 1539-1558
43. Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced metaanalysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008; 61: 991-996
44. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-Analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634
45. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101
46. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-Analysis. Biometrics. 2000; 56: 455-463
47. Stram DO, Hankin JH, Wilkens LR, et al. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study- (United States). Cancer Causes Control. 2006; 17: 1193-1207
48. Park E, Stacewicz-Sapuntzakis M, Sharifi R, et al. Diet adherence dynamics and physiological responses to a tomato product wholefood intervention in African-American men. Br J Nutr. 2013; 109: 2219-2230
49. Talvas J, Caris-Veyrat C, Guy L, et al. Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr. 2010; 91: 1716-1724
50. van Breemen RB, Sharifi R, Viana M, et al. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prev Res (Phila). 2011; 4: 711-718
51. Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood). 2002; 227: 886-893
52. Van Blarigan EL, Ma J, Kenfield SA, et al. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomarkers Prev. 2014; 23: 1037-1046
53. Parsons JK, Newman V, Mohler JL, et al. The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer. Urology. 2008; 72: 633-637
54. Parsons JK, Newman VA, Mohler JL, et al. Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study. BJU Int. 2008; 101: 1227-1231
55. Kucuk O, Sarkar FH, Djuric Z, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood). 2002; 227: 881-885
56. Clark PE, Hall MC, Borden LS Jr et al. Phase I-II prospective doseescalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006; 67: 1257-1261
57. Giovannucci E, Ascherio A, Rimm EB, et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995; 87: 1767-1776
58. Giovannucci E, Rimm EB, Liu Y, et al. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002; 94: 391-398
59. Mohanty NK, Saxena S, Singh UP, et al. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol Oncol. 2005; 23: 383-385
60. Porrini M, Riso P. What are typical lycopene intakes?. J Nutr. 2005; 135: 2042S-2045S
61. Leal J, Hamdy F, Wolstenholme J. Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies. IntJ Urol. 2014; 21: 786-792
62. Hu MB, Xu H, Bai PD, et al. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response metaanalysis of 36, 927 patients. Med Oncol. 2014; 31: 829
63. Yang CM, Yen YT, Huang CS, et al. Growth inhibitory efficacy of lycopene and beta-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res. 2011; 55: 606-612
64. Elgass S, Cooper A, Chopra M. Lycopene inhibits angiogenesis in human umbilical vein endothelial cells and rat aortic rings. Br J Nutr. 2012; 108: 431-439
65. Chen ML, Lin YH, Yang CM, et al. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res. 2012; 56: 889-899